TABLE 1.
Clinical characteristics of 46 patients with SARS‐Cov2 re‐infection between the first and the second epidemic wave in Marseille France
| Patients (n = 46) | First infection | Second infection | P value** | |
|---|---|---|---|---|
| Nb/total (%) | Nb/total (%) | |||
| Age | 50 ± 22 | |||
| Sex ratio (M/F) | 25/21 | |||
| Mean delay/SD (days) | 172 (90‐308) | |||
| Comorbidity | ||||
| NA | 7/46 | |||
| Any | 15/39 (38.4%) | |||
| None | 20 | |||
| Diabetes | 5 | |||
| Smoker | 1 | |||
| Hypertension | 8 | |||
| Heart underlying disease | 3 | |||
| Obesity BMI > 30 kg/m2 | 4 | |||
| Asthma | 4 | |||
| Cancer | 0 | |||
| Clinical presentation | Symptomatic | 39/46 (84.7) | 33/46 (71.7) | .102 |
| Mild/moderate | 37/39 (94.8) | 26/33 (78.7) | .044 | |
| Severe/critical | 2/39(5.1) | 7/33 (21.2) | .044 | |
| Asymptomatic | 7/46 (15.2) | 13/46 (28.2) | .102 | |
| Hospitalized | 11/46 (32.1) | 12/46 (26) | .500 | |
| ICU | 0/46 | 2/46 (4.3) | .247 | |
| Death | 0/46 | 2/46 (4.3) | .247 | |
| ICU or death in hospitalized patient | 0/46 | 4/46 (8.6) | .058 | |
Abbreviation: NA, not available.
**
Fisher exact test.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.